馬偕醫學院機構典藏(Mackay Medical College Institutional Repository):Item 987654321/1524
English  |  正體中文  |  简体中文  |  全文笔数/总笔数 : 1595/1694
造访人次 : 2867070      在线人数 : 152
RC Version 5.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜寻范围 进阶搜寻

jsp.display-item.identifier=請使用永久網址來引用或連結此文件: http://140.112.115.32:8080/ir/handle/987654321/1524

题名: The mood stabilizer valproate activates human FGF1 gene promoter through inhibiting HDAC and GSK-3 activities
作者: Chien-Yu Kao;Yi-Chao Hsu;Jen-Wei Liu;Don-Ching Lee;Yu-Fen Chung;Ing-Ming Chiu
贡献者: 聽語學系
关键词: FGF1;GSK-3;HDACs;lithium;RFX;VPA
日期: 2013-07-01
上传时间: 2015-03-16 15:48:02 (UTC+8)
摘要: Valproic acid (VPA) is the primary mood-stabilizing drug to exert neuroprotective effects and to treat bipolar disorder in clinic. Fibroblast growth factor 1 (FGF1) has been shown to regulate cell proliferation, cell division, and neurogenesis. Human FGF1 gene 1B promoter (−540 to +31)-driven green fluorescence (F1BGFP) has been shown to recapitulate endogenous FGF1 gene expression and facilitates the isolation of neural stem/progenitor cells (NSPCs) from developing and adult mouse brains. In this study, we provide several lines of evidence to demonstrate the underlying mechanisms of VPA in activating FGF-1B promoter activity: (i) VPA significantly increased the FGF-1B mRNA expression and the percentage of F1BGFP(+) cells; (ii) the increase of F1BGFP expression by VPA involves changes of regulatory factor X (RFX) 1-3 transcriptional complexes and the increase of histone H3 acetylation on the 18-bp cis-element of FGF-1B promoter; (iii) treatments of other histone deacetylases (HDAC) inhibitors, sodium butyrate and trichostatin A, significantly increased the expression levels of FGF-1B, RFX2, and RFX3 transcripts; (iv) treatments of glycogen synthase kinase 3 (GSK-3) inhibitor, lithium, or GSK-3 siRNAs also significantly activated FGF-1B promoter; (v) VPA specifically enhanced neuronal differentiation in F1BGFP(+) embryonic stem cells and NSPCs rather than GFP(−) cells. This study suggested, for the first time, that VPA activates human FGF1 gene promoter through inhibiting HDAC and GSK-3 activities.
關聯: Journal of Neurochemistry, 126(1), 4-18. https://doi.org/10.1111/jnc.12292
显示于类别:[聽力暨語言治療學系] 期刊論文

文件中的档案:

档案 描述 大小格式浏览次数
index.html0KbHTML166检视/开启


在MMCIR中所有的数据项都受到原著作权保护.

 


DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋